The US Departments of Justice and Health and Human Services recently issued a press release on the formation of a new False Claims Act Working Group, signaling to the healthcare industry an increased focus on anti-fraud enforcement efforts.
On July 2, 2025, the US Department of Justice (DOJ) and US Department of Health and Human Services (HHS) announced the creation of a False Claims Act Working Group (the Working Group), building upon their “long history of partnering” with one another “to combat healthcare fraud.”
The Working Group aligns with the US administration’s priority of focusing on combating waste, fraud, and abuse in government spending. The announcement of the Working Group sends a strong signal to the healthcare industry that the federal government expects to ramp up its anti-fraud enforcement efforts, including through greater reliance on data analytics to identify potential FCA enforcement targets. It will also likely lead to an increase in qui tam complaints.
Healthcare companies, including insurers, manufacturers of drug products, medical devices, and medical supplies, should remain vigilant and continue to assess their internal policies and procedures to remain compliant with complex federal and state laws that govern the delivery and billing of healthcare items and services.
The DOJ-HHS FCA Working Group includes the HHS Office of General Counsel, the Centers for Medicare and Medicaid Services Center for...
By Oscar Okhifo Life coach, Nancy Umeh has issued a public retraction and apology over her previous accusations against Nigerian gospel singer Mercy Chinwo and her husband, Pastor Blessed Uzochikw...